Efficacy and safety of pralsetinib in multiple endocrine neoplasia type 2-associated pheochromocytoma: a case report. [PDF]
Chen S +7 more
europepmc +1 more source
Medullary thyroid carcinoma and RET molecular testing: A virtual tumor board on clinical decision-making. [PDF]
Kallas-Silva L +7 more
europepmc +1 more source
Efficacy of iodine-131-metaiodobenzylguanidine therapy for multiple endocrine neoplasia type 2A-associated metastatic pheochromocytoma: case report and literature review. [PDF]
Suda K +12 more
europepmc +1 more source
Landscape of Phenotype-Genotype Correlations in Romanian Patients with Medullary Thyroid Carcinoma. [PDF]
Stanescu LS +6 more
europepmc +1 more source
Modeling the Effects of Single Nucleotide Polymorphisms (SNPs) on the Structure and Function of the Human <i>RET</i> Gene: An In Silico Study. [PDF]
Anzoom N +7 more
europepmc +1 more source
Advanced disease and biochemical phenotype shift in multiple endocrine neoplasia type 2A-related pheochromocytoma. [PDF]
Yanagida J +3 more
europepmc +1 more source
Support for Disclosure of Hereditary Tumor Risk to Children and Adolescents: A Scoping Review. [PDF]
Sugima K +4 more
europepmc +1 more source
Multiple Endokrine Neoplasie Typ 2 (MEN2) [PDF]
openaire +1 more source
Bilateral pheochromocytoma: case series and review of treatment strategies based on genetic mutations. [PDF]
Katsumi K +10 more
europepmc +1 more source
Multifocal papillary thyroid carcinoma with <i>RET p.V804M</i>, <i>EML4-ALK</i> fusion, and <i>BRAF V600E</i> positivity. [PDF]
Beiriger J +4 more
europepmc +1 more source

